Search

Karl E. Group

Examiner (ID: 16968, Phone: (571)272-1368 , Office: P/1731 )

Most Active Art Unit
1731
Art Unit(s)
1108, 1731, 1755, 2899, 1793
Total Applications
4063
Issued Applications
3169
Pending Applications
125
Abandoned Applications
770

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11713590 [patent_doc_number] => 20170182089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'ADMINISTRATION OF A THIOL-BASED CHEMOPROTECTANT COMPOUND' [patent_app_type] => utility [patent_app_number] => 15/284950 [patent_app_country] => US [patent_app_date] => 2016-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10530 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15284950 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/284950
ADMINISTRATION OF A THIOL-BASED CHEMOPROTECTANT COMPOUND Oct 3, 2016 Abandoned
Array ( [id] => 13461967 [patent_doc_number] => 20180282526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => AQUEOUS COMPOSITION COMPRISING DISPERSED ESTERIFIED CELLULOSE ETHER [patent_app_type] => utility [patent_app_number] => 15/764498 [patent_app_country] => US [patent_app_date] => 2016-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15764498 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/764498
Aqueous composition comprising dispersed esterified cellulose ether Sep 28, 2016 Issued
Array ( [id] => 13622015 [patent_doc_number] => 20180362559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => BONE ACTIVE NITROGEN-CONTAINING BISPHOSPHONATES WITH A NEAR INFRARED FLUORESCENT LABEL [patent_app_type] => utility [patent_app_number] => 15/761711 [patent_app_country] => US [patent_app_date] => 2016-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7452 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15761711 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/761711
BONE ACTIVE NITROGEN-CONTAINING BISPHOSPHONATES WITH A NEAR INFRARED FLUORESCENT LABEL Sep 20, 2016 Abandoned
Array ( [id] => 17349958 [patent_doc_number] => 11224576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-18 [patent_title] => Process for the production of an abuse-proofed dosage form [patent_app_type] => utility [patent_app_number] => 15/257079 [patent_app_country] => US [patent_app_date] => 2016-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11698 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15257079 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/257079
Process for the production of an abuse-proofed dosage form Sep 5, 2016 Issued
Array ( [id] => 11348745 [patent_doc_number] => 20160367485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM' [patent_app_type] => utility [patent_app_number] => 15/255218 [patent_app_country] => US [patent_app_date] => 2016-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12077 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255218 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/255218
PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM Sep 1, 2016 Abandoned
Array ( [id] => 16213866 [patent_doc_number] => 10729658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-04 [patent_title] => Process for the production of an abuse-proofed dosage form [patent_app_type] => utility [patent_app_number] => 15/255312 [patent_app_country] => US [patent_app_date] => 2016-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10577 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255312 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/255312
Process for the production of an abuse-proofed dosage form Sep 1, 2016 Issued
Array ( [id] => 11455800 [patent_doc_number] => 20170049706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => 'PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM' [patent_app_type] => utility [patent_app_number] => 15/255441 [patent_app_country] => US [patent_app_date] => 2016-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13221 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15255441 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/255441
PROCESS FOR THE PRODUCTION OF AN ABUSE-PROOFED DOSAGE FORM Sep 1, 2016 Abandoned
Array ( [id] => 13383801 [patent_doc_number] => 20180243442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-30 [patent_title] => POLY(VINYL ALCOHOL) NANOCARRIERS [patent_app_type] => utility [patent_app_number] => 15/752326 [patent_app_country] => US [patent_app_date] => 2016-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15752326 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/752326
Poly(vinyl alcohol) nanocarriers Aug 14, 2016 Issued
Array ( [id] => 11455984 [patent_doc_number] => 20170049891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-23 [patent_title] => '5-AMINOLEVULINIC ACID CONJUGATED QUANTUM DOT NANOPARTICLE' [patent_app_type] => utility [patent_app_number] => 15/235362 [patent_app_country] => US [patent_app_date] => 2016-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3297 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15235362 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/235362
5-AMINOLEVULINIC ACID CONJUGATED QUANTUM DOT NANOPARTICLE Aug 11, 2016 Abandoned
Array ( [id] => 11323707 [patent_doc_number] => 20160354318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-08 [patent_title] => 'LIPIDATED GLYCOPROTEIN PARTICLES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/228449 [patent_app_country] => US [patent_app_date] => 2016-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7420 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15228449 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/228449
LIPIDATED GLYCOPROTEIN PARTICLES AND METHODS OF USE Aug 3, 2016 Abandoned
Array ( [id] => 16335631 [patent_doc_number] => 10786569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-29 [patent_title] => Lithographically defined nanoparticles for microwave absorption [patent_app_type] => utility [patent_app_number] => 15/224562 [patent_app_country] => US [patent_app_date] => 2016-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 20 [patent_no_of_words] => 4017 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15224562 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/224562
Lithographically defined nanoparticles for microwave absorption Jul 30, 2016 Issued
Array ( [id] => 13328479 [patent_doc_number] => 20180215777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => COMPLEXES FOR INTRACELLULAR IMAGING [patent_app_type] => utility [patent_app_number] => 15/748336 [patent_app_country] => US [patent_app_date] => 2016-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19886 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748336 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/748336
COMPLEXES FOR INTRACELLULAR IMAGING Jul 28, 2016 Abandoned
Array ( [id] => 13311495 [patent_doc_number] => 20180207284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => FLUORESCENT PRODRUGS [patent_app_type] => utility [patent_app_number] => 15/745321 [patent_app_country] => US [patent_app_date] => 2016-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7219 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15745321 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/745321
Fluorescent prodrugs Jul 13, 2016 Issued
Array ( [id] => 11348965 [patent_doc_number] => 20160367705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'NANOPARTICLES COMPRISED OF SHELLS ASSOCIATED WITH CHARGED ENTITIES AND FORMED FROM MONOMERS AND METHODS OF MAKING AND USING NANOPARTICLES' [patent_app_type] => utility [patent_app_number] => 15/184822 [patent_app_country] => US [patent_app_date] => 2016-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13956 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15184822 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/184822
NANOPARTICLES COMPRISED OF SHELLS ASSOCIATED WITH CHARGED ENTITIES AND FORMED FROM MONOMERS AND METHODS OF MAKING AND USING NANOPARTICLES Jun 15, 2016 Abandoned
Array ( [id] => 11348947 [patent_doc_number] => 20160367688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'RAMAN-ACTIVE POLYMER PARTICLES AND METHODS FOR SYNTHESIZING THEREOF' [patent_app_type] => utility [patent_app_number] => 15/183489 [patent_app_country] => US [patent_app_date] => 2016-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8159 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15183489 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/183489
RAMAN-ACTIVE POLYMER PARTICLES AND METHODS FOR SYNTHESIZING THEREOF Jun 14, 2016 Abandoned
Array ( [id] => 13687293 [patent_doc_number] => 20170354601 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-14 [patent_title] => ION IMPLANTATION OF MAGNETIC ELEMENTS INTO NANODIAMOND PARTICLES TO FORM COMPOSITION FOR MEDICAL USAGE [patent_app_type] => utility [patent_app_number] => 15/180309 [patent_app_country] => US [patent_app_date] => 2016-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4213 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15180309 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/180309
ION IMPLANTATION OF MAGNETIC ELEMENTS INTO NANODIAMOND PARTICLES TO FORM COMPOSITION FOR MEDICAL USAGE Jun 12, 2016 Abandoned
Array ( [id] => 11728114 [patent_doc_number] => 20170189557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-06 [patent_title] => 'METHOD OF PREPARING FLUORESCENT SILK PROTEIN SOLUTION EXTRACTED FROM TRANSGENIC SILKWORM COCOONS AND METHOD OF MANUFACTURING SUPPORT USING THE SAME' [patent_app_type] => utility [patent_app_number] => 15/315935 [patent_app_country] => US [patent_app_date] => 2016-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3676 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315935 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/315935
METHOD OF PREPARING FLUORESCENT SILK PROTEIN SOLUTION EXTRACTED FROM TRANSGENIC SILKWORM COCOONS AND METHOD OF MANUFACTURING SUPPORT USING THE SAME Jun 9, 2016 Abandoned
Array ( [id] => 11082200 [patent_doc_number] => 20160279166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-29 [patent_title] => 'TREATING AGENT AND TREATING METHOD FOR THE EXAMINATION OR OPERATION OF THE LARGE INTESTINE' [patent_app_type] => utility [patent_app_number] => 15/173223 [patent_app_country] => US [patent_app_date] => 2016-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6195 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15173223 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/173223
TREATING AGENT AND TREATING METHOD FOR THE EXAMINATION OR OPERATION OF THE LARGE INTESTINE Jun 2, 2016 Abandoned
Array ( [id] => 13492629 [patent_doc_number] => 20180297857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => Aqueous Synthesis of Polyhedral "Brick-Like" Iron Oxide Nanoparticles for Hyperthermia and T2 MRI Contrast Enhancement, and for Targeting Endothelial Cells for Therapeutic Delivery [patent_app_type] => utility [patent_app_number] => 15/578907 [patent_app_country] => US [patent_app_date] => 2016-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6355 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15578907 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/578907
Aqueous Synthesis of Polyhedral "Brick-Like" Iron Oxide Nanoparticles for Hyperthermia and T2 MRI Contrast Enhancement, and for Targeting Endothelial Cells for Therapeutic Delivery May 24, 2016 Abandoned
Array ( [id] => 15338987 [patent_doc_number] => 10525150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-07 [patent_title] => Targeted contrast agents and methods for targeting contrast agents [patent_app_type] => utility [patent_app_number] => 15/155958 [patent_app_country] => US [patent_app_date] => 2016-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 12770 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15155958 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/155958
Targeted contrast agents and methods for targeting contrast agents May 15, 2016 Issued
Menu